Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $19.08, but opened at $18.25. Daiichi Sankyo shares last traded at $18.66, with a volume of 28,219 shares.
Daiichi Sankyo Trading Down 4.4%
The company’s 50 day moving average price is $18.93 and its two-hundred day moving average price is $21.91. The company has a debt-to-equity ratio of 0.18, a current ratio of 2.69 and a quick ratio of 1.85. The stock has a market capitalization of $33.85 billion, a PE ratio of 16.39, a P/E/G ratio of 1.13 and a beta of -0.35.
Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) last announced its quarterly earnings data on Thursday, January 29th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.05. Daiichi Sankyo had a net margin of 14.83% and a return on equity of 18.64%. The company had revenue of $3.65 billion during the quarter, compared to analysts’ expectations of $3.88 billion. As a group, analysts expect that Daiichi Sankyo Co., Ltd. – Sponsored ADR will post 0.73 earnings per share for the current year.
About Daiichi Sankyo
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Featured Stories
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
